RESUMO
Los anticoagulantes orales directos (ACOD) emergen como una alternativa más cómoda y segura que los clásicos antagonistas de la vitamina K (AVK); no precisan monitorización, poseen una ventana terapéutica más amplia y tienen menos interacciones farmacológicas. Sin embargo, a pesar de que su uso está cada vez más extendido, existe poco consenso sobre cuál es su manejo perioperatorio óptimo en cirugía dermatológica. En este artículo se describen las características de los ACOD y se revisa la evidencia disponible sobre su uso perioperatorio en la cirugía de la piel
Direct-acting oral anticoagulants (DOACs) have emerged as safer, easier-to-manage alternatives to traditional vitamin K antagonists and are used increasingly because they require no monitoring, have a wider therapeutic window, and react less with other drugs. However, there is little consensus on optimal perioperative management when these drugs are used in dermatologic surgery. This article describes the characteristics of DOACs and reviews current evidence on their use in this setting
Assuntos
Humanos , Anticoagulantes/administração & dosagem , Dermatopatias/cirurgia , Procedimentos Cirúrgicos Dermatológicos/métodos , Perda Sanguínea Cirúrgica/prevenção & controle , Administração OralRESUMO
Direct-acting oral anticoagulants (DOACs) have emerged as safer, easier-to-manage alternatives to traditional vitamin K antagonists and are used increasingly because they require no monitoring, have a wider therapeutic window, and react less with other drugs. However, there is little consensus on optimal perioperative management when these drugs are used in dermatologic surgery. This article describes the characteristics of DOACs and reviews current evidence on their use in this setting.
Assuntos
Anticoagulantes , Inibidores do Fator Xa , Administração Oral , Anticoagulantes/efeitos adversos , Procedimentos Cirúrgicos Dermatológicos , Inibidores do Fator Xa/uso terapêutico , Fibrinolíticos/uso terapêuticoRESUMO
No disponible
